Clinical characteristics and risk factors of pulmonary embolism with Mycoplasma pneumoniae pneumonia in children.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
14 10 2024
14 10 2024
Historique:
received:
05
06
2024
accepted:
25
09
2024
medline:
15
10
2024
pubmed:
15
10
2024
entrez:
14
10
2024
Statut:
epublish
Résumé
Pulmonary embolism is a rare but serious complication in Mycoplasma pneumoniae pneumonia patients, leading to serious sequelae and even death. We aim to retrospectively analyze the clinical features of Mycoplasma pneumoniae pneumonia with pulmonary consolidation in children and to explore the independent risk factors for progression to pulmonary embolism. Clinical data of 207 children with Mycoplasma pneumoniae pneumonia complicated with pulmonary consolidation were collected, and the patients were divided into the pulmonary embolism group (69 patients) and the control group (138 patients). Multivariate logistic regression was used to analyze the risk factors and the predictive efficacy was evaluated by receiver operating characteristic curve. Multivariate logistic regression analysis showed that fever days, D-dimer, immunoglobulin A, chest pain, extra-respiratory symptoms, plastic bronchitis and cutaneous mucosal system complications were the independent risk factors. Fever days ≥ 7.5, D-dimer ≥ 0.895 mg/L, immunoglobulin A ≥ 1.015 g/L, chest pain, extra-respiratory symptoms, plastic bronchitis and cutaneous mucous system complications significantly increased the risk of pulmonary embolism in children with Mycoplasma pneumoniae pneumonia complicated with pulmonary consolidation.
Identifiants
pubmed: 39402105
doi: 10.1038/s41598-024-74302-x
pii: 10.1038/s41598-024-74302-x
doi:
Substances chimiques
Fibrin Fibrinogen Degradation Products
0
fibrin fragment D
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
24043Subventions
Organisme : the Joint construction project of Henan Province medical science and technology research
ID : SB201903028
Informations de copyright
© 2024. The Author(s).
Références
Waites, K. B., Xiao, L., Liu, Y., Balish, M. F. & Atkinson, T. P. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin. Microbiol. Rev. 30(3), 747–809. https://doi.org/10.1128/CMR.00114-16 (2017).
doi: 10.1128/CMR.00114-16
pubmed: 28539503
pmcid: 5475226
Li, Z. J. et al. Etiological and epidemiological features of acute respiratory infections in China. Nat. Commun. 12(1), 5026. https://doi.org/10.1038/s41467-021-25120-6 (2021).
doi: 10.1038/s41467-021-25120-6
pubmed: 34408158
pmcid: 8373954
Liu, J. et al. Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children’s hospital. BMC Infect. Dis. 20(1), 51. https://doi.org/10.1186/s12879-020-4774-9 (2020).
doi: 10.1186/s12879-020-4774-9
pubmed: 31948402
pmcid: 6966865
Kim, K. et al. Global trends in the proportion of macrolide-resistant mycoplasma pneumoniae infections: A systematic review and meta-analysis. JAMA Netw. Open 5(7), e2220949. https://doi.org/10.1001/jamanetworkopen.2022.20949 (2022).
doi: 10.1001/jamanetworkopen.2022.20949
pubmed: 35816304
pmcid: 9274321
Moynihan, K. M. et al. Severe mycoplasma pneumoniae infection in children admitted to pediatric intensive care. Pediatr. Infect. Dis. J. 37(12), e336–e338. https://doi.org/10.1097/inf.0000000000002029 (2018).
doi: 10.1097/inf.0000000000002029
pubmed: 29912842
Jin, X. et al. Assessment of levels of D-dimer and interferon-γ in pediatric patients with Mycoplasma pneumoniae pneumonia and its clinical implication. Exp. Therap. Med. 16(6), 5025–5030. https://doi.org/10.3892/etm.2018.6873 (2018).
doi: 10.3892/etm.2018.6873
Chen, L. et al. Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children. Clin. Respir. J. 17(3), 187–196. https://doi.org/10.1111/crj.13584 (2023).
doi: 10.1111/crj.13584
pubmed: 36658687
pmcid: 9978901
China, N. H. C o t P s R o, Guidelines for diagnosis and treatment of mycoplasma pneumoniae pneumonia in children. China Licensed Pharmacist 20(3), 16–24 (2023).
Kutty, P. K. et al. Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia. Clin. Infect. Dis. 68(1), 5–12. https://doi.org/10.1093/cid/ciy419 (2019).
doi: 10.1093/cid/ciy419
pubmed: 29788037
Waites, K. B. & Talkington, D. F. Mycoplasma pneumoniae and its role as a human pathogen. Clin. Microbiol. Rev. 17(4), 697–728. https://doi.org/10.1128/cmr.17.4.697-728.2004 (2004). table of contents.
doi: 10.1128/cmr.17.4.697-728.2004
pubmed: 15489344
pmcid: 523564
Witmer, C. M., Steenhoff, A. P., Shah, S. S. & Raffini, L. J. Mycoplasma pneumoniae, splenic infarct, and transient antiphospholipid antibodies: A new association? Pediatrics 119(1), e292-5. https://doi.org/10.1542/peds.2006-1340 (2007).
Snowden, N., Wilson, P. B., Longson, M. & Pumphrey, R. S. Antiphospholipid antibodies and Mycoplasma pneumoniae infection. Postgrad. Med. J. 66(775), 356–362. https://doi.org/10.1136/pgmj.66.775.356 (1990).
doi: 10.1136/pgmj.66.775.356
pubmed: 2371184
pmcid: 2426843
Li, T. et al. Evaluation of variation in coagulation among children with Mycoplasma pneumoniae pneumonia: A case-control study. J. Int. Med. Res. 45 (6), 2110–2118. https://doi.org/10.1177/0300060517709613 (2017).
doi: 10.1177/0300060517709613
pubmed: 28643533
pmcid: 5805204
Lichota, A., Gwozdzinski, K. & Szewczyk, E. M. Microbial Modulation of Coagulation disorders in venous thromboembolism. J. Inflamm. Res. 13, 387–400. https://doi.org/10.2147/jir.S258839 (2020).
doi: 10.2147/jir.S258839
pubmed: 32801832
pmcid: 7406375
Narita, M. Pathogenesis of neurologic manifestations of Mycoplasma pneumoniae infection. Pediatr. Neurol. 41(3). https://doi.org/10.1016/j.pediatrneurol.2009.04.012 (2009). 159 – 66.
Song, S. & Xu, Y. A retrospective study of the clinical characteristics of 9 children with pulmonary embolism associated with Mycoplasma pneumoniae pneumonia. BMC Pediatr. 23(1), 370. https://doi.org/10.1186/s12887-023-04188-7 (2023).
doi: 10.1186/s12887-023-04188-7
pubmed: 37474910
pmcid: 10360226
Freund, Y., Cohen-Aubart, F. & Bloom, B. Acute pulmonary embolism: A review. JAMA 328(13), 1336–1345. https://doi.org/10.1001/jama.2022.16815 (2022).
doi: 10.1001/jama.2022.16815
pubmed: 36194215
Sheng, C-Q., Yang, C-F., Ao, Y., Zhao, Z-Y. & Li, Y-M. Mycoplasma pneumoniae pneumonia with pulmonary embolism: A study on pediatric cases in Jilin Province of China. Exp. Therap. Med. 21(3), 201. https://doi.org/10.3892/etm.2021.9634 (2021).
doi: 10.3892/etm.2021.9634
Han, C. et al. Analysis of the risk factors and clinical features of Mycoplasma pneumoniae pneumonia with embolism in children: a retrospective study. Ital. J. Pediatr. 48(1), 153. https://doi.org/10.1186/s13052-022-01344-0 (2022).
doi: 10.1186/s13052-022-01344-0
pubmed: 35987653
pmcid: 9391649
Maughan, B. C., Jarman, A. F., Redmond, A., Geersing, G-J. & Kline, J. A. Pulmonary embolism. BMJ (Clinical research ed.), 384: p. e071662. https://doi.org/10.1136/bmj-2022-071662 (2024).
Konstantinides, S. V. et al. ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur. Heart J. 41(4), 543–603. (2019). https://doi.org/10.1093/eurheartj/ehz405
Hennelly, K. E. et al. Detection of pulmonary embolism in high-risk children. J. Pediatr. 178, 214–218. https://doi.org/10.1016/j.jpeds.2016.07.046 (2016). .e3.
doi: 10.1016/j.jpeds.2016.07.046
pubmed: 27567411
Gu, H., Li, B., Han, Y., Yang, S. & Wang, X. Risk factors for suspected pulmonary embolism in children: Complication of Mycoplasma pneumoniae pneumonia. Eur. J. Radiol. 176, 111474. https://doi.org/10.1016/j.ejrad.2024.111474 (2024).
doi: 10.1016/j.ejrad.2024.111474
pubmed: 38696918
Zhu, Y. et al. Immune response plays a role in Mycoplasma pneumoniae pneumonia. Front. Immunol. 14, 1189647. https://doi.org/10.3389/fimmu.2023.1189647 (2023).
doi: 10.3389/fimmu.2023.1189647
pubmed: 37304280
pmcid: 10250694
Hansen, I. S., Baeten, D. L. P. & Dunnen, J. The inflammatory function of human IgA. Cell. Mol. Life Sci. 76(6), 1041–1055. https://doi.org/10.1007/s00018-018-2976-8 (2019).
doi: 10.1007/s00018-018-2976-8
pubmed: 30498997
Jiang, Y. et al. Serum amyloid a, C-reactive protein, and procalcitonin levels in children with Mycoplasma pneumoniae infection. J. Clin. Lab. Anal. 36(3), e24265. https://doi.org/10.1002/jcla.24265 (2022).
doi: 10.1002/jcla.24265
pubmed: 35148010
pmcid: 8906050
Zhang, X., Sun, R., Jia, W., Li, P. & Song, C. Clinical characteristics of lung consolidation with Mycoplasma pneumoniae pneumonia and risk factors for mycoplasma pneumoniae necrotizing pneumonia in children. Infect. Dis. Therapy https://doi.org/10.1007/s40121-023-00914-x (2024).
doi: 10.1007/s40121-023-00914-x
Huang, J-J., Yang, X-Q., Zhuo, Z-Q. & Yuan, L. Clinical characteristics of plastic bronchitis in children: A retrospective analysis of 43 cases. Respir. Res. 23(1), 51. https://doi.org/10.1186/s12931-022-01975-1 (2022).
doi: 10.1186/s12931-022-01975-1
pubmed: 35248022
pmcid: 8898471
Yang, L. et al. Clinical features and risk factors of plastic bronchitis caused by Mycoplasma pneumoniae pneumonia in children. BMC Pulm. Med. 23(1), 468. https://doi.org/10.1186/s12890-023-02766-0 (2023).
doi: 10.1186/s12890-023-02766-0
pubmed: 37996853
pmcid: 10668422
Kimura, S. et al. Histological characteristics of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in asthmatic murine model during A(H1N1)pdm09 infection. Pathol. Int. 72(10), 506–518. https://doi.org/10.1111/pin.13268 (2022).
doi: 10.1111/pin.13268
Berlot, J. R., Mrvič, T., Košnik, M. & Keše, D. The association between Mycoplasma pneumoniae genotype and cutaneous disease. Microorganisms. 11 (1). https://doi.org/10.3390/microorganisms11010205 (2023).
Sauteur, P. M. M. et al. Frequency and clinical presentation of mucocutaneous disease due to Mycoplasma pneumoniae infection in children with community-acquired pneumonia. JAMA Dermatol.. 156 (2), 144–150. https://doi.org/10.1001/jamadermatol.2019.3602 (2020).
doi: 10.1001/jamadermatol.2019.3602
Haseeb, A. et al. Ocular involvement in mycoplasma induced rash and mucositis: A systematic review of the literature. Ocul. Surf. 28, 1–10. https://doi.org/10.1016/j.jtos.2022.11.007 (2023).
doi: 10.1016/j.jtos.2022.11.007
pubmed: 36396020